Neurocrine Biosciences
NBIX
#1537
Rank
โ‚ฌ10.24 B
Marketcap
102,77ย โ‚ฌ
Share price
-1.76%
Change (1 day)
-21.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

P/S ratio for Neurocrine Biosciences (NBIX)

P/S ratio as of March 2025 (TTM): 4.68

According to Neurocrine Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.26. At the end of 2024 the company had a P/S ratio of 5.99.

P/S ratio history for Neurocrine Biosciences from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.99-12.62%
20236.86-11.06%
20227.718.2%
20217.13-16.75%
20208.56-31.97%
201912.6-12.4%
201814.4-66.18%
201742.5-81.05%
2016224-9.2%
2015247
2014N/A-100%
20132162204.11%
20129.3554.16%
20116.07-51.52%
201012.5-69.11%
200940.530.41%
200831.1-78.11%
20071421310.15%
200610.1-46.46%
200518.8-11.08%
200421.152.7%
200313.8-82.15%
200277.6105.49%
200137.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
11.3 141.86%๐Ÿ‡บ๐Ÿ‡ธ USA
7.83 67.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
44.2 842.84%๐Ÿ‡บ๐Ÿ‡ธ USA
16.2 246.79%๐Ÿ‡บ๐Ÿ‡ธ USA
6.53 39.53%๐Ÿ‡บ๐Ÿ‡ธ USA
2.22-52.57%๐Ÿ‡บ๐Ÿ‡ธ USA
2.38-49.09%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 122.41%๐Ÿ‡บ๐Ÿ‡ธ USA